OMEZA, LLC
Omeza is a skin health company dedicated to restoring skin integrity for people with serious skin problems and optimizing skin quality for all. They develop marine-based products, including the OCM™ wound matrix, to support all phases of wound healing, reduce biofilm formation, decrease inflammation, increase tissue proliferation, and support skin remodeling. Their mission is to deliver complete wound care simply and effectively, aiming to prevent costly hospital admissions and amputations associated with chronic wounds.
Industries
Nr. of Employees
small (1-50)
Products
Acellular peptide-based wound matrix (single-use vial)
An absorbable, conformable acellular wound matrix formulated with marine-derived peptides and pharmaceutical-grade components, intended for weekly clinician-administered application to chronic, non-healing wounds.
Acellular peptide-based wound matrix (single-use vial)
An absorbable, conformable acellular wound matrix formulated with marine-derived peptides and pharmaceutical-grade components, intended for weekly clinician-administered application to chronic, non-healing wounds.
Services
Clinical trials and study support
Designs and runs randomized, open-label, multi-center and real-world clinical studies to evaluate wound-healing performance and secondary endpoints.
Provider education and sales training
Training programs and materials for clinicians and distributor sales teams to support point-of-care application and product integration into outpatient workflows.
Commercial distribution and logistics (via national partner)
National commercialization, logistics, ordering, and customer service provided through an exclusive distribution partner for outpatient settings and federal channels.
Reimbursement and payor access support
Engagement pathways for reimbursement and payor communication, including dedicated resources for federal customers (VA, DOD, IHS).
Clinical trials and study support
Designs and runs randomized, open-label, multi-center and real-world clinical studies to evaluate wound-healing performance and secondary endpoints.
Provider education and sales training
Training programs and materials for clinicians and distributor sales teams to support point-of-care application and product integration into outpatient workflows.
Commercial distribution and logistics (via national partner)
National commercialization, logistics, ordering, and customer service provided through an exclusive distribution partner for outpatient settings and federal channels.
Reimbursement and payor access support
Engagement pathways for reimbursement and payor communication, including dedicated resources for federal customers (VA, DOD, IHS).
Expertise Areas
- Regenerative skin and wound care
- Clinical trial management for wound therapies
- Biomaterial formulation and productization
- Analytical testing and lab-based evaluation
Key Technologies
- Acellular peptide-based wound matrix
- Marine-derived peptide formulations
- Absorbable conformable wound matrices
- Randomized controlled trial and real-world study methodologies